why does the N501Y thing have them worried?
because it is a change on the spike protein "key" (for the ACE2/CD147 "lock") for entry into cells. "the" vaccines target the spike protein.
N501Y means an amino-acid has changed from N to Y ar the 501'st position.
the 70% quoted is just statistical analysis of the population disease numbers and flow.
now they have to test the virus itself.
it could be nothing BUT
i. it's like "due process" for the virus, with the first question being is there "prima facie evidence"; to which they have decided 'yes'.
ii. mutations can be starting points for further mutations.
-
results pending:
US army scientists examine new UK coronavirus variant to see if it might be resistant to vaccine
By
Elizabeth Cohen, CNN Senior Medical Correspondent
Updated 0153 GMT (0953 HKT) December 21, 2020
"Scientists at the Walter Reed Army Institute of Research expect to know in the next few days if there's a concern that the coronavirus vaccines might not work against a mutated variant of the virus that's rapidly spreading in parts of England, according to the institute's top vaccine researcher.
While there's always a worry that a vaccine won't work if a virus mutates significantly, the Walter Reed scientists still expect the vaccine will be effective against this new variant, said Dr. Nelson Michael, director of the Center for Infectious Diseases Research at the Walter Reed Army Institute of Research."
US army scientists examine new UK coronavirus variant to see if it might be resistant to vaccine - CNN
"[UK] Scientists in race to prove whether vaccine effective against new Covid strain
Government scientists are in a race to prove that vaccines can fend off the new strain of Covid-19 as experts warned the variant could render jabs “less effective”.
Scientists at the Porton Down facility in Wiltshire are growing samples of the new strain before adding serum taken from vaccinated patients to test the response. The results are expected in a “couple of weeks,” Whitehall sources said."
Scientists in race to prove whether vaccine effective against new Covid strain